Latest News & Insights
Stay Up to Date with Our Community
Featured
Electra Therapeutics, Inc. today announced the pricing of its upsized initial public offering of 23,333,334 shares of common stock at...
Electra Therapeutics, Inc. today announced the pricing of its upsized initial...
Latigo Biotherapeutics, Inc. (“Latigo”), a clinical-stage biopharmaceutical company committed to developing...
$2.5 million grant supports clinical trial activation and patient screening efforts...
Targeting clinically validated pathways to enable patients to achieve freedom from...
Recludix today announced preclinical data for REX-8756, an oral, potent and...
Star Therapeutics to receive $1.25 billion upfront, with up to $750...
Majority of patients met the American College of Rheumatology improvement criteria...
ORJ-001 achieved therapeutic exposure and was well tolerated in Phase 1...
Company announces $30 million Series A financing and founding leadership team...